Even as researchers seek for biomarkers to forecast ketamine reaction, clinicians discover on their own with a conundrum: Which patients ought to start with IV ketamine, and which with Spravato? And how do the two compare head to head in true reaction to treatment? Patients have a major advancement in https://johna693koq0.blog-a-story.com/profile